Prostate Cancer - Results from #40

Health-related quality of life of advanced prostate cancer patients and spouses: results from actor-partner interdependence models. May 17, 2022

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets. May 16, 2022

Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. May 16, 2022

Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis. May 16, 2022

Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone. May 16, 2022

Mediterranean Style Dietary Pattern with High Intensity Interval Training in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Pilot Randomised Control Trial. May 16, 2022

Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series. May 13, 2022

Prostate cancer survivor capacity to engage in survivorship self-management: a comparison of perceptions between oncology specialists, primary care, and survivors. May 13, 2022

Bone Uptake in Prostate Cancer Patients: Diagnostic Performances of PSMA-RADS v1.0, Clinical, Biological, and 68Ga-PSMA-11 PET Features to Predict Metastasis After Biochemical Recurrence. May 13, 2022

Diagnostic Performance of a Magnetic Resonance Imaging-directed Targeted plus Regional Biopsy Approach in Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis. May 13, 2022

Association between baseline body mass index and survival in men with metastatic hormone-sensitive prostate cancer: ECOG-ACRIN CHAARTED E3805. May 13, 2022

Patient-Reported Outcomes in a Prostate Cancer Hypofractionation Trial. May 12, 2022

NeuroSAFE in radical prostatectomy increases nerve-sparing surgery without affecting oncological outcome. May 12, 2022

Social support, anxiety, and depression in patients with prostate cancer: complete mediation of self-efficacy. May 12, 2022

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery and Follow-up. May 12, 2022

Geographic Variability, Time Trends and Association of Preoperative MRI with Surgical Outcomes for Elderly US Men with Prostate Cancer: A SEER-Medicare Analysis. May 12, 2022

Association of Patient and Imaging-Related Factors with False Negative MRI-Targeted Prostate Biopsies of Suspicious PI-RADS 4 and 5 Lesions. May 11, 2022

Radiation therapy compared to radical prostatectomy as first-line definitive therapy for patients with high-risk localised prostate cancer: An updated systematic review and meta-analysis. May 11, 2022

Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison. May 11, 2022

Prostate-Specific Membrane Antigen as Target for Neuroimaging of Central Nervous System Tumors. May 11, 2022

Page 3 of 1224

email news signup